Recent posts and comments

• BG Medicine Eyes $70M IPO, Nano-Terra Picks Up $17.2M, Rive Technology Raises $25M, & More Boston-Area Deals News

  Lots of nice deals to report this week from New England’s tech and life sciences sectors.

  —E-mail archiving provider Sonian indicated to the SEC that it had raised $4 million in an... Read more »

• SmartCells Finds Potential $500M+ Exit, EnerNOC Acquires Global Energy Partners, Azuki Adds $4M, & More Boston-Area Deals News

  New England’s tech and life sciences companies were busy this week. Here are some of the deals they inked.

  —Waltham, MA-based research tools and services provider Thermo Fisher Scientific (NYSE:TMO) ... Read more »

• Heartland Reaps $20M, CloudBees Gathers $4M, Adimab Acquires $4M, & More Boston-Area Deals News

  A number of New England tech and life sciences companies had deals to be thankful for this week.

  —CloudBees, a startup soon to be headquartered in Boston, raised $4 million in a Series A financing... Read more »

• EMC Shells Out $2.25B for Isilon, Cerulean Secures $24M, Kayak Files for IPO, & More Boston-Area Deals News

  This week saw deals inked in all corners of New England’s innovation ecosystem, but the biggie was in IT.

  —Regulatory filings indicate that Kala Pharmaceuticals raised $3 million in an equity and... Read more »

• Oracle Buys ATG for $1B, Acquia Raises $8.5M, Boston Scientific Sells Unit to Stryker for $1.5B, & More Boston-Area Deals News

  If you like deals with a “billion” in them, this was the week for you.

  —Software maker Neohapsis of Cambridge, MA, raised $4.5 million in a deal led by New Venture Partners and... Read more »

• Novartis to Invest $600M in Cambridge Complex

  Swiss pharma behemoth Novartis, already Cambridge, MA’s biggest corporate employer, planns to invest $600 million more in a new 4 acre office and lab complex here, according to a report on the Boston... Read more »

• Trimble Scoops Up ThingMagic, Resolvyx Sells Option to Celtic Therapeutics, GSK Venture Arm Puts $4M into Dicerna, & More Boston-Area Deals News

  Dealmaking activity was on the light side this week in the New England tech and life sciences sectors, but there are still some interesting items to report.

  —Search-engine developer Goby raised $2.5... Read more »

• Find The Investor of Your Dreams—For Free

  There’s all sorts of wisdom about how to find folks to invest in your startup, ranging from the obvious to the slightly stalkerish. Approach investors who’ve supported companies like yours in... Read more »

• Spark Capital Gathers $360M Worth of Kindling, 1366 Technologies Nabs $20M, NinePoint Medical Pinpoints $33M, & More Boston-Area Deals News

  IT companies dominated this week’s deals news in New England. Here are some highlights.

  —Online videogame maker Quick Hit raised $2.5 million in equity financing, according to an SEC filing. The... Read more »

• Marvell Backs OLPC Tablet With $5.6M, Sanofi-Aventis’ Makes Takeover Bid for Genzyme, $7M Lands in The Echo Nest, & More Boston-Area Deals News

  A French drugmaker’s bid to acquire one of New England’s biggest biotechs turned hostile this week. Read on for this, and some of the week’s less predictable deals news from the... Read more »

• Merck Ends Aveo Deal, Acceleron Rides Pharma Partnership Wave, Rhythmia Raises $5M, & More Boston-Area Life Sciences News

  The birth and death of partnerships was the subject of much of this week’s news in New England’s life sciences sector.

  —Rhythmia Medical raised $5 million in an equity offering that... Read more »

• Novartis Edges Out Biogen Idec in Oral MS Drug Race, Ironwood Sells Microbia to DSM, RXi Teams With Eyegate, & More Boston-Area Life Sciences News

  It was New England’s public life sciences companies that made the most news in the sector this week.

  —Ryan chatted with Mark Corrigan, CEO of Zalicus (NASDAQ: ZLCS), about the Cambridge,... Read more »

• IBM Acquires Netezza and OpenPages, Boston Scientific Buys Asthmatx, Massachusetts Startup Financing Rebounds, & More Boston-Area Deals News

  Big Blue is gobbling up all of New England’s IT companies—or at least that’s the impression you’d get from this week’s deals news.

  —IBM (NYSE: IBM) announced it will acquire Waltham,... Read more »

• Ironwood Drug Passes Clinical Test, Genzyme Cuts Jobs and Sheds Business Unit, Third Rock Closes $426M Fund, & More Boston-Area Life Sciences News

  All eyes continued to be on Genzyme this week, but other New England life sciences companies had interesting developments to report as well.

  —Good Start Genetics, a three-year-old Boston startup built in part... Read more »

• Genzyme Sheds Testing Unit, Red Bend Acquires VirtualLogix, Acceleron Forges Alliance with Shire, & More Boston-Area Deals News

  New England’s life sciences companies inked the majority of this week’s deals, but several software firms had interesting business to report as well.

  —Boston-based startup Rhythm Pharmaceuticals completed its Series A financing round... Read more »

• Pfizer Axes Celldex Agreement, Vertex’s Telaprevir Performs in Clinical Trial, Anchor Therapeutics Inks Potential $480M Deal With J&J, & More Boston-Area Life Sciences News

  —Needham, MA-based Celldex Therapeutics announced that Pfizer (NYSE: PFE) had terminated a agreement in which it licensed Celldex’s experimental cancer vaccine rindopepimut, because it no longer views the drug as... Read more »

• Commenting on: The Leaning Tower of Ping: How iTunes Could Be Apple’s Undoing

  Rebecca said: @Lk: If you’ve got a dog who’s a better tech journalist than Wade Roush, then I’ve got a desk, computer, and 401k for... Read more »

• PrimeraDx Names New CEO

  PrimeraDx, a Mansfield, MA-based developer of molecular diagnostic technology, has named Matthew F. McManus as its new president and chief executive, the company announced today. The startup, which raised $20 million in... Read more »

• Former Sirtris Execs Sell Resveratrol Via New Nonprofit, Dicerna Closes $25M Deal, ViThera Combats Gut Disease With Engineered Bacteria, & More Boston-Area Life Sciences News

  [Updated 8/13/2010 9:30 EST. See below.] New England’s biotech and healthcare sector yielded a number of interesting stories this week.

  —Joanna Horobin, CEO of Syndax Pharmaceuticals, confirmed that the Waltham, MA-based... Read more »

• Blue Cod and Viridity Bag $8M Apiece, Aprendica and Arbor Networks Acquired, & More Boston-Area Deals News

  New England’s tech and life sciences firms had a busy week raising money and inking acquisition deals. So much for the summer slow-down!

  —Blue Cod Technologies announced it has raised $8 million... Read more »